— Know what they know.
Not Investment Advice

008930.KS KSC

Hanmi Science Co., Ltd.
1W: +6.1% 1M: +20.7% 3M: +80.4% YTD: +22.9% 1Y: +27.6% 3Y: +79.2% 5Y: -22.6%
₩55,300.00 ($41.17)
+2600.00 (+4.93%)
 
Weekly Expected Move ±8.7%
₩45722 ₩50511 ₩55300 ₩60089 ₩64878
KSC · Healthcare · Medical - Distribution · Tech Score Buy · Power 64 · ₩3.74T mcap · 13M float · 2.08% daily turnover
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩3.74T ($2.8B)
52W Range25600-61000
Volume167,452
Avg Volume279,691
Beta0.45
Dividend₩400.00
Analyst Ratings
No analyst coverage
Company Info
CEOJong-Hoon Lim
Employees489
SectorHealthcare
IndustryMedical - Distribution
IPO Date2005-09-29
14, Wiryeseong-daero
Seoul, GY 05545
KR
82 2 410 9114
About Hanmi Science Co., Ltd.

Hanmi Science Co., Ltd. operates through its subsidiaries to produce and distribute pharmaceutical products both within South Korea and internationally. The company's research and development initiatives primarily target treatments for diabetes and various types of cancer. Its extensive product line further includes active pharmaceutical ingredients, general therapeutic drugs, nutritional supplements, and a variety of health-related goods and services. Additionally, it manages an online pharmacy platform and provides automated systems for pharmaceutical administration. The firm, which was initially established as Hanmi Holdings Co., Ltd. in 1973, adopted its current name, Hanmi Science Co., Ltd., in March 2012, and its corporate headquarters are situated in Seoul, South Korea.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms